About Triveni Formulations Limited
Data last updated:
Triveni Formulations Limited is a public limited company based in Vijayawada, Andhra Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 January 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24239AP2006PLC048778. Its GSTIN is 37AACCT3908R1ZQ (Andhra Pradesh).
The company has an authorised share capital of ₹4.5 Cr and a paid-up capital of ₹4.44 Cr. It is led by directors including Vasudevagupta Tunuguntla (Managing Director) and Indukumari Tunuguntla.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No. 40 – 1 – 90 Plot No.201 Sultan Palia Khanna Nagar Benz Circle, Vijayawada, Andhra Pradesh, India – 520010.
As per the financials filed for FY 2025, the company reported a revenue of ₹10.9 Cr, a decline of 15% compared to the previous year. For the same year it recorded a net profit of ₹1.28 Cr (net margin 11.8%) and EBITDA of ₹2.68 Cr (EBITDA margin 24.6%). Revenue has grown at a compounded annual rate (CAGR) of 372% over three years and 7% over five years.
The company has about 39 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹8.28 Cr and satisfied charges of ₹4.54 Cr on record. Court records list 13 cases involving the company, including 3 filed by the company and 10 filed against it; 3 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website triveniformulations.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressH.No. 40 – 1 – 90 Plot No.201 Sultan Palia Khanna Nagar Benz Circle, Vijayawada, Andhra Pradesh, India – 520010
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Triveni Formulations Limited
The main business activity of Triveni Formulations is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Triveni Formulations Limited FY 2025 filings available
Triveni Formulations Limited reported revenue of ₹10.9 Cr (down 15% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Triveni Formulations Limited
Revenue fell 15% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 7%. EBITDA fell 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Triveni Formulations Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹10.9 Cr | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.68 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.28 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Triveni Formulations Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 24.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 11.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Triveni Formulations are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Triveni Formulations Limited
Triveni Formulations Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Triveni Formulations Limited this company | ₹10.9 Cr (FY 2025) | •••• | •••• | -15.0% | •••• | Vijayawada, Andhra Pradesh, India |
| G.D. Laboratories (India) Private Limited | ₹10.81 Cr (FY 2024) | •••• | •••• | -6.0% | •••• | New Delhi, Delhi, India |
| SG Lifecare Private Limited | ₹10.81 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Rajkot, Gujarat, India |
| Appian Properties Private Limited | ₹10.8 Cr (FY 2025) | •••• | •••• | -8.0% | •••• | New Delhi, Delhi, India |
| Ray Life Sciences Private Limited | ₹10.79 Cr (FY 2024) | •••• | •••• | 71.0% | •••• | Bangalore, Karnataka, India |
| Artisan Netcom (India) Private Limited | ₹10.78 Cr (FY 2024) | •••• | •••• | 70.0% | •••• | New Delhi, Delhi, India |
| D M Pharma (MKT.) Private Limited | ₹10.76 Cr (FY 2025) | •••• | •••• | -12.0% | •••• | Chandigarh, India |
| Oncobiotek Formulations Private Limited | ₹10.73 Cr (FY 2025) | •••• | •••• | 25.0% | •••• | Ahmedabad, Gujarat, India |
| Embellish Pharma Tech Private Limited | ₹10.72 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Roorkee, Uttarakhand, India |
| Elite Pharma Private Limited | ₹10.71 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Ahmedabad, Gujarat, India |
| Biogenomics Limited | ₹10.7 Cr (FY 2023) | •••• | •••• | 30.0% | •••• | Pondicherry, India |
Peers are the five companies nearest above and the five nearest below Triveni Formulations by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Triveni Formulations Limited
Triveni Formulations Limited is audited by DURGA SHYAM SUNDAR & CO for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| DURGA SHYAM SUNDAR & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Triveni Formulations Limited
Triveni Formulations has 5 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vasudevagupta Tunuguntla | Managing Director | 18 Jan 2006 | 20 Years 8 Months | Current |
| Indukumari Tunuguntla | Director | 16 Jan 2006 | 20 Years 8 Months | Current |
| Parvathaneni Srinivasa Rao | Director | 16 Jan 2006 | 20 Years 8 Months | Current |
| Padma Parvathineni | Director | 05 Feb 2014 | 12 Years 8 Months | Current |
| Gopalakrishna Bavirisetty | Director | 05 Feb 2014 | 12 Years 8 Months | Current |
Ownership and Shareholding of Triveni Formulations Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Triveni Formulations Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 May 2017 | Hdfc Bank Limited | ₹8.28 Cr | Open |
| 02 Feb 2010 | Others | ₹2.19 Cr | Satisfied |
| 09 Aug 2006 | Ing Vysya Bank Ltd | ₹2.35 Cr | Satisfied |
Total charge records: 3 View all charges
Legal Cases of Triveni Formulations Limited
Triveni Formulations Limited has 13 court cases on record: 3 filed by Triveni Formulations, 10 filed against it. 3 cases are pending and 10 are disposed. Status as checked between 21 Sep 2026 and 02 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 10 | 7 | 3 |
| High courts | 3 | 3 | 0 |
Cases on record (5 of 13)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (LPETN) | Filed against the company by Sun Pharma Laboratories Limited | Disposed |
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Sun Pharma Laboratories Limited | Disposed |
| Bombay High Court | Court case (COMIP) | Filed against the company by Sun Pharma Laboratories Limited | Disposed |
| District court, MYSURU, Karnataka | Criminal complaint | Filed against the company by State at the Instance of Assistant Drugs Controller, Mysuru | Pending |
| District court, East Godavari, Andhra Pradesh | Criminal complaint | Filed against the company by an individual | Pending |
Full case history
All 13 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Triveni Formulations Limited
Triveni Formulations Limited has a workforce of 39 employees as of Oct 10, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Triveni Formulations Limited
Triveni Formulations has one previous CIN (Corporate Identification Number): U24239TG2006PLC048778. The current CIN is U24239AP2006PLC048778, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239AP2006PLC048778 | Current |
| U24239TG2006PLC048778 | Previous |
Recent Activity on Triveni Formulations Limited
Triveni Formulations Limited has 7 board changes on record since 2006: 5 appointments and 2 cessations. The latest: Vellampalli Prabhavathi ceased to be Director on 19 Oct 2022.
6 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Triveni Formulations Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Triveni Formulations Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Triveni Formulations Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Triveni Formulations Limited
Triveni Formulations has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AACCT3908R1ZQ | Andhra Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Triveni Formulations Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Triveni Formulations Limited
Triveni Formulations is an active public limited company based in Vijayawada, Andhra Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 January 2006 (20+ years old) and is registered under CIN U24239AP2006PLC048778.
Triveni Formulations reported revenue of ₹10.9 Cr for FY 2025 (down 15% YoY).
Triveni Formulations has 5 current directors:
- Vasudevagupta Tunuguntla - Managing Director
- Indukumari Tunuguntla - Director
- Parvathaneni Srinivasa Rao - Director
- Padma Parvathineni - Director
- Gopalakrishna Bavirisetty - Director
Triveni Formulations reported a net profit of ₹1.28 Cr (net margin 11.8%) and EBITDA of ₹2.68 Cr (EBITDA margin 24.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Triveni Formulations is 372% over three years and 7% over five years. In the latest year (FY 2025) revenue fell 15%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Triveni Formulations is 37AACCT3908R1ZQ, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Triveni Formulations is U24239AP2006PLC048778. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Triveni Formulations has 13 court cases on record: 3 filed by the company and 10 filed against it. 3 are pending. Most are in the district courts.
Triveni Formulations was incorporated on 16 January 2006, making it 20+ years old. It is registered with the Registrar of Companies, Vijayawada.
The peers of Triveni Formulations by revenue are G.D. Laboratories (India) Private Limited, SG Lifecare Private Limited, Appian Properties Private Limited, Ray Life Sciences Private Limited, Artisan Netcom (India) Private Limited and 5 more, all in the Pharma industry (Formulations).
Vellampalli Prabhavathi ceased to be Director on 19 Oct 2022. Kurmala Ranga Rao ceased to be Director on 10 Aug 2015. Gopalakrishna Bavirisetty was appointed as Director on 05 Feb 2014. Triveni Formulations has 7 board changes on record in total.